Page 72 - MONOGRAFIA 25, de Esclerosis multiple

FACTORES AMBIENTALES
DE LA ESCLEROSIS MÚLTIPLE
72
BIBLIOGRAFÍA
1. Simpson S, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(10):1132-41.
2. Correale J, Farez MF, Gaitán MI. Environmental factors influencing multiple sclerosis in Latin
America. Mult Scler J Exp Transl Clin. 2017;3(2):2055217317715049.
3. Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk
factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25-36.
4. Amato MP, Derfuss T, Hemmer B, Liblau R, Montalban X, Soelberg Sørensen P, et al. Environ-
mental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused
workshop. Mult Scler. 2017 Jan 6:1352458516686847 [Epub ahead of print].
5. Bagur MJ, Murcia MA, Jiménez-Monreal AM, Tur JA, Bibiloni MM, Alonso GL, et al. Influence
of Diet in Multiple Sclerosis: a Systematic Review. Adv Nutr Bethesda Md. 2017;8(3):463-72.
6. Fleck A-K, Schuppan D, Wiendl H, Klotz L. Gut–CNS-Axis as Possibility to Modulate Inflamma- tory Disease Activity-Implications for Multiple Sclerosis. Int J Mol Sci. 2017;18(7). Disponible en:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536015/.
7. Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, et al. Contribution of di-
etary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry.
2018;89(1):28-33.
8. Altowaijri G, Fryman A, Yadav V. Correction to: Dietary Interventions and Multiple Sclerosis. Curr
Neurol Neurosci Rep. 2017;17(12):93.
9. Saresella M, Mendozzi L, Rossi V, Mazzali F, Piancone F, LaRosa F, et al. Immunological and
Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pi- lot Study. Front Immunol. 2017;8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC5661395/.
10. Altowaijri G, Fryman A, Yadav V. Correction to: Dietary Interventions and Multiple Sclerosis. Curr Neurol Neurosci Rep. 2017;17(12):93.
11. Burgos R, Bretón I, Cereda E, Desport JC, Dziewas R, Genton L, et al. ESPEN guideline clinical nutrition in neurology. Clin Nutr. 2018;37(1):354-96.
12. Claflin SB, Mei IAF van der, Taylor BV. Complementary and alternative treatments of multiple scle- rosis: a review of the evidence from 2001 to 2016. J Neurol Neurosurg Psychiatry. 2018;89(1):34-41. 13. Hammer A, Schliep A, Jörg S, Haghikia A, Gold R, Kleinewietfeld M, et al. Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation. J Neuroinflammation. 2017;14. Disponible en: https://www.ncbi.nlm.
nih.gov/pmc/articles/PMC5596846/.
14. Esposito S, Bonavita S, Sparaco M, Gallo A, Tedeschi G. The role of diet in multiple sclerosis: a
review. Nutr Neurosci. 2018 Jul;21(6):377-90.
15. Fitzgerald KC, Munger KL, Hartung H-P, Freedman MS, Montalbán X, Edan G, et al. Sodium
intake and multiple sclerosis activity and progression in BENEFIT. Ann Neurol. 2017;82(1):20-9.
16. Gili-Miner M, López-Méndez J, Vilches-Arenas A, Ramírez-Ramírez G, Franco-Fernández D, Sa- la-Turrens J, et al. Multiple sclerosis and alcohol use disorders: in-hospital mortality, extended
hospital stays, and overexpenditures. Neurol Barc Spain. 2018;33(6): 351-9.
17. Paz-Ballesteros WC, Monterrubio-Flores EA, Jesús Flores-Rivera J de, Corona-Vázquez T, Hernán- dez-Girón C. Cigarette Smoking, Alcohol Consumption and Overweight in Multiple Sclerosis:
Disability Progression. Arch Med Res. 2017;48(1):113-20.